Strategic Manufacturing Partnership for SENT-001 Cell Therapy

planned

Made Scientific and Sentinel BioTherapeutics have announced a strategic manufacturing partnership to support the Phase I/II clinical development of SENT-001, an allogeneic encapsulated cell therapy. Made Scientific will establish a new GMP Master Cell Bank and support process optimization and clinical GMP drug product manufacturing of SENT-001 as an off-the-shelf product, enabling re-dosing and combination with targeted immunotherapy drugs. The manufacturing strategy introduces a closed, scalable production model to enhance operational efficiency, increase throughput, and reduce manufacturing time and cost of goods, facilitating clinical scalability and economic sustainability.